Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study - PubMed (original) (raw)
Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study
Tobias Kurth et al. BMJ. 2009.
Erratum in
- BMJ. 2009;339:b2769
Abstract
Objective: To evaluate the association of kidney function with cardiovascular disease and mortality among apparently healthy women.
Design: Prospective cohort study.
Setting: Women's Health Study, United States.
Participants: 27 939 female health professionals aged >or=45 who were free of cardiovascular disease and other major disease and who provided a blood sample at study entry.
Main outcome measures: Time to cardiovascular disease (non-fatal stroke, non-fatal myocardial infarction, coronary revascularisation procedures, or death from cardiovascular cause), specific cardiovascular disease events, and all-cause mortality. End points were confirmed after review of medical records and death certificates.
Results: Glomerular filtration rate (GFR) was estimated with the abbreviated Modification of Diet in Renal Disease Study equation. At baseline, 1315 (4.7%) women had GFR <60 ml/min/1.73 m(2). During 12 years of follow-up, 1199 incident cardiovascular disease events and 856 deaths (179 from cardiovascular disease) occurred. Compared with women with GFR >or=90 ml/min/1.73 m(2), the multivariable adjusted hazard ratios for any first cardiovascular disease were 0.95 (95% CI 0.83 to 1.08), 0.84 (0.70 to 1.00), and 1.00 (0.79 to 1.27) among women with GFR of 75-89.9, 60-74.9, and <60 ml/min/1.73 m(2), respectively; the equivalent hazard ratios for all cause mortality were 0.93 (0.79 to 1.09), 1.03 (0.85 to 1.26), and 1.09 (0.83 to 1.45). Similar null findings were observed for myocardial infarction, stroke, coronary revascularisation, and non-cardiovascular death. However, an increased risk of death from cardiovascular disease was found among women with GFR <60 ml/min/1.73 m(2) (hazard ratio 1.68 (1.02 to 2.79)).
Conclusions: In this large cohort of women, a glomerular filtration rate <60 ml/min/1.73 m(2) was associated with increased risk of cardiovascular disease death but not other cardiovascular disease events or non-cardiovascular disease mortality. We observed no increase in risk of any of the outcomes among women with less severe impairment of kidney function.
Conflict of interest statement
Competing interests: None declared, but we report a full disclosure for the past five years. TK has received research funding from Merck, McNeil Consumer & Specialty Pharmaceuticals, the National Institutes of Health, and Wyeth Consumer Healthcare; is a consultant to i3 Drug Safety and World Health Information Science Consultants, LLC; and received honorariums from Genzyme, Merck, and Pfizer for lectures. PEdJ has received research funding from the Dutch Kidney Foundation. NRC has received research funding and support from the National Institutes of Health and from Roche Molecular Systems. JEB has received research funding and support from Dow Corning Corporation and the National Institutes of Health; research support from Bayer Heath Care and the Natural Source Vitamin E Association; honorariums from Bayer for lectures; and serves on an external scientific advisory committee for a study by Procter & Gamble. PMR has received research funding and support from the American Heart Association, AstraZeneca, Bayer, Bristol-Myers Squibb, Dade-Behring, Doris Duke Charitable Foundation, James and Polly Annenberg La Vea Charitable Trusts, Leducq Foundation, the National Institutes of Health, Novartis, Merck, Donald W Reynolds Foundation, Pharmacia, Roche, Sanofi/Aventis, and Variagenics; is listed as coinventor on patents held by Brigham and Women’s Hospital on the use of inflammatory biomarkers in cardiovascular disease; and has served as consultant to AstraZeneca, Dade-Behring, Interleukin Genetics, Isis Pharmaceuticals, Sanofi/Aventis, and Schering-Plough,
Comment in
- Kidney function and the risk of cardiovascular disease.
Weiner DE, Rifkin DE. Weiner DE, et al. BMJ. 2009 Jun 29;338:b1307. doi: 10.1136/bmj.b1307. BMJ. 2009. PMID: 19564177 No abstract available.
Similar articles
- Electrocardiogram abnormalities and cardiovascular mortality in elderly patients with CKD.
Dobre M, Brateanu A, Rashidi A, Rahman M. Dobre M, et al. Clin J Am Soc Nephrol. 2012 Jun;7(6):949-56. doi: 10.2215/CJN.07440711. Epub 2012 Mar 29. Clin J Am Soc Nephrol. 2012. PMID: 22461533 - Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS. Shlipak MG, et al. Ann Intern Med. 2006 Aug 15;145(4):237-46. doi: 10.7326/0003-4819-145-4-200608150-00003. Ann Intern Med. 2006. PMID: 16908914 - Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.
Ford I, Bezlyak V, Stott DJ, Sattar N, Packard CJ, Perry I, Buckley BM, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J. Ford I, et al. PLoS Med. 2009 Jan 20;6(1):e16. doi: 10.1371/journal.pmed.1000016. PLoS Med. 2009. PMID: 19166266 Free PMC article. - Insulin resistance underlies the elevated cardiovascular risk associated with kidney disease and glomerular hyperfiltration.
Adeva-Andany MM, Fernández-Fernández C, Carneiro-Freire N, Castro-Quintela E, Pedre-Piñeiro A, Seco-Filgueira M. Adeva-Andany MM, et al. Rev Cardiovasc Med. 2020 Mar 30;21(1):41-56. doi: 10.31083/j.rcm.2020.01.5102. Rev Cardiovasc Med. 2020. PMID: 32259903 Review. - Causes and consequences of lipoprotein(a) abnormalities in kidney disease.
Kronenberg F. Kronenberg F. Clin Exp Nephrol. 2014 Apr;18(2):234-7. doi: 10.1007/s10157-013-0875-8. Epub 2013 Oct 16. Clin Exp Nephrol. 2014. PMID: 24129557 Review.
Cited by
- Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis.
Li N, Zhou G, Zheng Y, Lv D, Zhu X, Wei P, Zheng M, Liu S, Zhou E, Sun W, Zhang L. Li N, et al. PLoS One. 2022 Jan 12;17(1):e0261986. doi: 10.1371/journal.pone.0261986. eCollection 2022. PLoS One. 2022. PMID: 35020750 Free PMC article. - Metabolic healthy obesity is associated with higher incidence of mild decrease estimate glomerular rate in rural northeast Chinese.
Yu S, Guo X, Li GX, Yang H, Zheng L, Sun Y. Yu S, et al. BMC Nephrol. 2020 Nov 24;21(1):505. doi: 10.1186/s12882-020-02164-2. BMC Nephrol. 2020. PMID: 33234109 Free PMC article. - Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A. Nitta K, et al. Clin Exp Nephrol. 2019 Jan;23(1):85-98. doi: 10.1007/s10157-018-1605-z. Epub 2018 Jun 27. Clin Exp Nephrol. 2019. PMID: 29951723 Free PMC article. - Estimated Glomerular Filtration Rate, Proteinuria, and Risk of Cardiovascular Diseases and All-cause Mortality in Diabetic Population: a Community-based Cohort Study.
Wang A, Chen G, Cao Y, Liu X, Su Z, Luo Y, Zhao Z, Li X, Chen S, Wu S, Guo X. Wang A, et al. Sci Rep. 2017 Dec 20;7(1):17948. doi: 10.1038/s41598-017-17965-z. Sci Rep. 2017. PMID: 29263432 Free PMC article. - Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women.
Yun BH, Chon SJ, Cho SH, Choi YS, Lee BS, Seo SK. Yun BH, et al. J Menopausal Med. 2016 Dec;22(3):167-173. doi: 10.6118/jmm.2016.22.3.167. Epub 2016 Dec 31. J Menopausal Med. 2016. PMID: 28119897 Free PMC article.
References
- US Renal Data System (USRDS). USRDS 2008 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008.
- Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171. - PubMed
- Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(4 suppl 1):117-31. - PubMed
- Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69. - PubMed
- Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 2007;167(11):1130-6. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 CA047988-09/CA/NCI NIH HHS/United States
- R01 HL080467-01/HL/NHLBI NIH HHS/United States
- R01 CA047988-16/CA/NCI NIH HHS/United States
- R01 CA047988-13/CA/NCI NIH HHS/United States
- R01 HL043851-09/HL/NHLBI NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- R01 CA047988-11/CA/NCI NIH HHS/United States
- R01 HL080467-02/HL/NHLBI NIH HHS/United States
- R01 CA047988-15/CA/NCI NIH HHS/United States
- R01 CA047988-14/CA/NCI NIH HHS/United States
- CA-047988/CA/NCI NIH HHS/United States
- HL-043851/HL/NHLBI NIH HHS/United States
- R01 CA047988-17/CA/NCI NIH HHS/United States
- R01 CA047988-10/CA/NCI NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- R01 HL043851-10/HL/NHLBI NIH HHS/United States
- HL-080467/HL/NHLBI NIH HHS/United States
- R01 CA047988-18/CA/NCI NIH HHS/United States
- R01 CA047988-12/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical